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Objectives and Results: The aim of our study was to present a case
of a leukemic patient with possible sphenoid sinus aspergilloma and
to evaluate the diagnostic value of the detection of the GM anti-
gen. Case report: A patient with AML (M4/FAB) is hospitalized with
recurrence of the illness since September 2007. Since 15 November
2007, he has been presenting neutropenia. From the date of the
admission until 28 November 2007, 51 cultures of several biologic
materials were performed and 8 serum samples were examined
for detection of the GM antigen, using a double sandwich assay
ELISA (Sanofi Diagnostics Pasteur). All the laboratory tests found
negative for fungi. At 29 November 2007 the patient presented
paresis of the left abducens nerve and fever. At 30 November 2007
the serum sample for GM was positive (r=0.77, n.v<0.5) and the
brain-splachnic skull CT showed almost complete takeover of the
left sphenoid sinus from a solid mass. At 3 December 2007 GM was
detected in CSF (strongly positive, r=7.18), as well as in a new
serum sample (r=0.78).The CSF culture was negative, whereas the
cytologic test ruled out the possibility of infiltration with leukemic
cells. According to these findings and the possible diagnosis of as-
pergillosis, the patient was treated with liposomic amphotericin
and caspofungin. Three more serum samples followed, until 10 De-
cember 2007, which were found positive for GM with progressively
raising titre (r=2.61), whereas ups and downs of the titre were
observed in 4 samples until 19 December 2007 (r=1.26-2.75).The
detection of GM in CSF at 17 December 2007 was again strongly
positive. Aspergillus was not isolated in any of the 14 cultures that
were performed. The patient is being hospitalized under treat-
ment, afebrile, in good shape and with stable x-ray findings.
Conclusions: The detection of GM antigen, in as many serum sam-
ples as possible from high risk patients, seems to contribute to
early diagnosis and therapeutic management of aspergillosis.
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Background: Removal of central venous catheter (CVC) from pa-
tients with candidemia is considered to be the standard of care.
Objective: To evaluate the epidemiology and the impact of early
versus delayed CVC removal on mortality of patients who survived
more than 72h after the first positive blood culture.
Patients and Methods: Between January 2001 and June 2005 a
prospective cohort study involving 192 hospitalized cancer patients
with CVC and candidemia was conducted at a tertiary cancer cen-
ter in Brazil. The study enrolled 164 patients who survived >3 days
and had their catheters removed during the study period. Patients
with CVC removal within 3 days of candidemia onset were classified
as having an early CVC removal. Overall mortality was evaluated
30 days after the index positive blood culture.
Results: Early CVC removal occurred in 61% of cases (100 of 164)
with a median removal time of 2 days (range 0-29 days). Patients
with early CVC removal differed significantly from those with de-
layed CVC removal, and they were more often female, had poor
performance status, other associated infected sites, short-duration
catheter type, and previous history of bacteremia, total parenteral
nutrition, and admission to intensive care unit. Multivariate anal-
ysis showed only the short-duration catheter type as significantly
associated with early removal. Overall mortality rate was 10.4% (17
of 164). CVC removal within 72h did not show a favorable impact
on mortality when compared with delayed removal (11% vs. 9.4%;
P=0.94). Multivariate analysis revealed that adults, lymphoma,
presence of comorbidities, use of steroid therapy, long-duration
neutropenia (>7 days) after the first positive blood culture, and
isolation of C. glabrata, C. krusei and C. tropicalis species from
blood cultures were independently associated with death.
Conclusion: Despite the significant difference in clinical charac-
teristics between patients with early and delayed CVC removal,
only short-duration catheter type was independently associated
with early removal. We were not able to demonstrate any ben-
eficial impact of early CVC removal on mortality among patients
who survived more than 72h after the index positive blood culture.
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Background: Disseminated trichosporonosis, caused by species of
the fungus Trichosporon, develops in neutropenic patients and is
described as a breakthrough infection that may develop even dur-
ing the use of antifungal drugs. However, little is known about the
current epidemiology of this disease. We organized an epidemio-
logic study of trichosporonosis to clarify the background and actual
treatment of trichosporonemia in Japan.
Materials and Methods: We sent a questionnaire about dissemi-
nated trichosporonosis to 459 hospitals throughout Japan that have
a physician specializing in hematology. Case reports with clinical
information on past cases with blood culture yielding Trichosporon
species from January 2000 to January 2008 were returned to us.
The risk factors, presence/absence of breakthrough infection, out-
come and efficacy of antifungal regimens for trichosporonemia
were investigated using these case reports.
Results: We received 48 case reports of trichosporonemia from
28 institutions. The most common underlying disease was acute
myeloid leukemia, which accounted for 62.5% (30) of cases. Of the
48 cases, 79.2% had neutropenia (polymorphonuclear leukocytes
< 500/mm3). Prior to onset of infection, 87.5% (42 cases) had
received several antifungal agents. The most common antifungal
agent administered before onset of trichosporonemia was mica-
fungin (28 of 42 cases; 66.7%), while 21 cases were administered
this drug for more than two weeks. Although various treatment
regimens were used for trichosporonosis, the mortality rate within
30 days was 70.8% in this study. Only voriconazole was significantly
effective for survival over 30 days after detection of this fungi
in blood (survival rate; 66.7%), compared with regimens without
voriconazole (P<0.05).
Conclusions: Trichosporonosis is a life-threatening infection in
cases of hematological malignancy, and is sometimes observed
even during long-term administration of micafungin in Japan. Tri-
chosporon species do not show sensitivity to echinocandin anti-
fungal drugs, and thus trichosporonosis would develop as a break-
through infection with the use of micafungin. This clinical data in-
dicates that voriconazole is an effective agent for trichosporonosis
in patients with hematological disease.
